发布: 2020年10月20日第10卷第20期 DOI: 10.21769/BioProtoc.3791 浏览次数: 3247
评审: Imre GáspárIndranil MalikRakesh Chatrikhi
相关实验方案
用于全面分析细胞、细胞外囊泡和血浆 RNA 中编码和非编码 RNA 生物型的 TGIRT-seq 方法
Hengyi Xu [...] Alan M. Lambowitz
2021年12月05日 5749 阅读
Abstract
The 5′ cap is a ubiquitous feature of eukaryotic mRNAs. It is added in the nucleus onto newly synthesized pre-mRNA, and in the cytoplasm onto mRNAs after decapping or endonuclease cleavage. Cytoplasmic recapping can occur after loss of the cap at the native 5′ end, or downstream within the body of the mRNA. The identification and location of recapping events is key to understanding the functional consequences of this process. Here we present an approach that addresses this problem, using the Lexogen TeloPrime® cDNA synthesis kit to tag recapped 5′ ends. TeloPrime uses a proprietary DNA ligase to add a double stranded DNA oligonucleotide onto the 3′ end of cDNA while it is base paired with mRNA. Specificity for capped ends is obtained by the oligonucleotide having an unpaired C residue that base pairs weakly with m7G on the mRNA 5′ end. This is followed by PCR amplification of double-stranded cDNA using primers to the appended oligonucleotide and the mRNA of interest. The resulting products are gel purified and sequenced directly (if a single band) or cloned and sequenced. The sequence at the junction between the ligated oligonucleotide and the target mRNA provides the location of the cap on the corresponding transcript. This assay is applicable to all capped transcripts. It can be used with Sanger sequencing for small numbers of transcripts or adapted for use with Illumina library sequencing.
Keywords: 5′ Cap (5'帽子)Background
The N7-methylguanosine cap is a distinguishing feature of all eukaryotic mRNAs. Proteins binding to the cap function all stages of the mRNA lifecycle, including nuclear processing, export, translation and mRNA decay. The 5′ cap is added co-transcriptionally to all mRNAs, and a number of genome wide techniques (e.g., Capped Analysis of Gene Expression, or CAGE) (Morioka et al., 2020) have been developed that use the identification of capped ends as a way to mark transcription initiation sites. In addition to marking transcription start sites approximately 25% of CAGE tags map downstream within spliced introns (Djebali et al., 2012). Evidence of the biochemical basis for this came from our lab’s identification in 2009 of a cytoplasmic complex capable of restoring the N7-methylguanosine cap onto transcripts with a 5′-monophosphate end, but not onto transcripts with a 5′-hydroxyl end (Otsuka et al., 2009). Cytoplasmic capping is catalyzed by a complex of enzymes including capping enzyme (RNGTT), cap methyltransferase (RNMT) and its activating subunit (RAM), and a kinase that converts the 5′-monophosphate ends of decapped transcripts to a 5′-diphosphate substrate for GMP addition (Trotman and Schoenberg, 2019). Our early work was based on use of a dominant negative form of capping enzyme that blocks cytoplasmic capping at the GMP addition step. Expression of this protein resulted in the appearance of a number of uncapped transcripts whose ends were mapped using 5’-RACE to the vicinity of downstream CAGE tags (Kiss et al., 2015; Berger et al., 2019). While encouraging, this approach has three major drawbacks; a) it requires separation of capped and uncapped RNAs, b) it assumes uncapped transcripts remain sufficiently stable to be detected, and c) it assumes uncapped ends detected in this manner have undergone limited additional exonucleolytic trimming.
These issues were resolved by the development of a new approach to inhibiting cytoplasmic capping that instead targets cap methylation (Del Valle Morales et al., 2020). Inhibition of cytoplasmic cap methylation results in the creation of recapped mRNAs with unmethylated G caps which are degraded by cap surveillance enzymes (Grudzien-Nogalska and Kiledjian, 2017). This makes it possible to identify cytoplasmic capping targets by quantitative changes in RNA-Seq data, thus eliminating assumptions about the stability and detectability of uncapped RNAs, the need to separate uncapped from capped RNAs, and concerns for exonucleolytic trimming. By simplifying the process of identifying cytoplasmic capping targets this approach makes it possible to study this process in any cells or tissues expressing the cytoplasmic cap methylation inhibitor. Finally, because these transcripts retain their caps, we paired this approach with a facile method for identifying capped ends that can be scaled from a few mRNAs to larger sequencing libraries.
Materials and Reagents
Equipment
Software
Procedure
文章信息
版权信息
© 2020 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
del Valle Morales, D. and Schoenberg, D. R. (2020). Analyzing (Re)Capping of mRNA Using Transcript Specific 5' End Sequencing. Bio-protocol 10(20): e3791. DOI: 10.21769/BioProtoc.3791.
分类
分子生物学 > RNA > RNA 加帽
分子生物学 > RNA > 转录
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link